Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Anthrax bacteria can infect and destroy hair follicles in mice, but the immune system eventually clears the infection.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Cholesterol affects coronavirus spread and could be a target for treatment.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Combination antibiotic therapy is more effective but causes more side effects.

Low testosterone may indicate severe COVID-19 in men.

Fungal infections in lab animals can interfere with research.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Terbinafine can cause hair loss.

A man got heart infection from scalp infection caused by artificial hair implants.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Obesity worsens skin health and losing weight can improve skin conditions.

COVID-19 infection is linked to temporary hair loss in Egyptian women.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Online medical education helps doctors make better clinical decisions and increases their knowledge in treating fungal nail infections.

Low-level laser therapy combined with Neoptide improved hair regrowth better than either treatment alone in rats.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

The document concludes that skin and nail changes can indicate various underlying health conditions.